AURORA INNOVATION INC (AUR)

US0517741072 - Common Stock

6.5  -0.32 (-4.69%)

After market: 6.47 -0.03 (-0.46%)

Fundamental Rating

3

Overall AUR gets a fundamental rating of 3 out of 10. We evaluated AUR against 280 industry peers in the Software industry. AUR has a great financial health rating, but its profitability evaluates not so good. AUR does not seem to be growing, but still is valued expensively.



0

1. Profitability

1.1 Basic Checks

AUR had negative earnings in the past year.
In the past year AUR has reported a negative cash flow from operations.
AUR had negative earnings in each of the past 5 years.
In the past 5 years AUR always reported negative operating cash flow.

1.2 Ratios

With a Return On Assets value of -35.62%, AUR is not doing good in the industry: 80.59% of the companies in the same industry are doing better.
AUR has a Return On Equity of -40.10%. This is in the lower half of the industry: AUR underperforms 65.20% of its industry peers.
Industry RankSector Rank
ROA -35.62%
ROE -40.1%
ROIC N/A
ROA(3y)-47.4%
ROA(5y)-38.01%
ROE(3y)-53.1%
ROE(5y)-43.43%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for AUR so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

8

2. Health

2.1 Basic Checks

AUR does not have a ROIC to compare to the WACC, probably because it is not profitable.
AUR has more shares outstanding than it did 1 year ago.
AUR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

AUR has an Altman-Z score of 25.23. This indicates that AUR is financially healthy and has little risk of bankruptcy at the moment.
AUR has a Altman-Z score of 25.23. This is amongst the best in the industry. AUR outperforms 93.77% of its industry peers.
There is no outstanding debt for AUR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 25.23
ROIC/WACCN/A
WACC11.53%

2.3 Liquidity

AUR has a Current Ratio of 10.96. This indicates that AUR is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of AUR (10.96) is better than 97.44% of its industry peers.
A Quick Ratio of 10.96 indicates that AUR has no problem at all paying its short term obligations.
AUR's Quick ratio of 10.96 is amongst the best of the industry. AUR outperforms 97.44% of its industry peers.
Industry RankSector Rank
Current Ratio 10.96
Quick Ratio 10.96

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 31.94% over the past year.
Looking at the last year, AUR shows a very negative growth in Revenue. The Revenue has decreased by -100.00% in the last year.
EPS 1Y (TTM)31.94%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
Revenue 1Y (TTM)-100%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

AUR is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 10.94% yearly.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y11.62%
EPS Next 2Y10.86%
EPS Next 3Y9.7%
EPS Next 5Y10.94%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. Valuation

4.1 Price/Earnings Ratio

AUR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for AUR. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y10.86%
EPS Next 3Y9.7%

0

5. Dividend

5.1 Amount

AUR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

AURORA INNOVATION INC

NASDAQ:AUR (1/6/2025, 5:12:49 PM)

After market: 6.47 -0.03 (-0.46%)

6.5

-0.32 (-4.69%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)10-30 2024-10-30/amc
Earnings (Next)N/A N/A
Inst Owners63.21%
Inst Owner Change0%
Ins Owners0.96%
Ins Owner Change0.18%
Market Cap11.17B
Analysts50.77
Price Target4.72 (-27.38%)
Short Float %6.4%
Short Ratio5.7
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)14.4%
Min EPS beat(2)12.74%
Max EPS beat(2)16.06%
EPS beat(4)3
Avg EPS beat(4)8.44%
Min EPS beat(4)-1.84%
Max EPS beat(4)16.06%
EPS beat(8)6
Avg EPS beat(8)20.69%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)24.39%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)2.42%
EPS NY rev (3m)2.05%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-35.35%
Revenue NY rev (3m)-69.68%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 5.63
P/tB 8.17
EV/EBITDA N/A
EPS(TTM)-0.49
EYN/A
EPS(NY)-0.46
Fwd EYN/A
FCF(TTM)-0.36
FCFYN/A
OCF(TTM)-0.35
OCFYN/A
SpS0
BVpS1.16
TBVpS0.8
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -35.62%
ROE -40.1%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-47.4%
ROA(5y)-38.01%
ROE(3y)-53.1%
ROE(5y)-43.43%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 71.43%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 10.96
Quick Ratio 10.96
Altman-Z 25.23
F-Score3
WACC11.53%
ROIC/WACCN/A
Cap/Depr(3y)149.34%
Cap/Depr(5y)174.12%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)31.94%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
EPS Next Y11.62%
EPS Next 2Y10.86%
EPS Next 3Y9.7%
EPS Next 5Y10.94%
Revenue 1Y (TTM)-100%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-13.15%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year25.13%
EBIT Next 3Y9.02%
EBIT Next 5Y14.64%
FCF growth 1Y-17.21%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-17.72%
OCF growth 3YN/A
OCF growth 5YN/A